Physician profile
Kyle Strickland
NPI 1649972944
$338.35
in general payments reported to CMS, 2019-2025
8 companies · $152 in 2025
The $152 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $114 · 2024: $72.77 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $338.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $113.85 | 2023 | Breztri |
| Lilly USA, LLC | $71.85 | 2025 | Mounjaro, Zepbound |
| Ucb, INC. | $56.31 | 2024-2025 | Briviact, Fintepla |
| Merck Sharp & Dohme LLC | $25.33 | 2024 | Lynparza, Keytruda |
| Glaxosmithkline, LLC. | $21.71 | 2025 | Trelegy Ellipta |
| Amgen INC. | $17.04 | 2024 | Evenity, Prolia |
| Abbvie INC. | $16.75 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.51 | 2024 | Gattex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Strickland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.